Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response.
Document Type
Journal Article
Publication Date
8-31-2018
Journal
Oncotarget
Volume
9
Issue
68
Inclusive Pages
33030-33042
DOI
10.18632/oncotarget.26050
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
APA Citation
Nilubol, N., Boufraqech, M., Zhang, L., Gaskins, K., Shen, M., Zhang, Y., Gara, S., Austin, C., & Kebebew, E. (2018). Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response.. Oncotarget, 9 (68). http://dx.doi.org/10.18632/oncotarget.26050
Peer Reviewed
1
